ImageneBio (IMA) Interest & Investment Income (2021 - 2025)

ImageneBio has disclosed Interest & Investment Income across 5 years of filings, most recently posting -$96000.0 for Q3 2025.

• Interest & Investment Income for Q3 2025 came in at -$96000.0, down 308.7% year-over-year; the trailing twelve-month figure through Sep 2025 was $8.1 million (up 28.26% YoY), and the FY2024 annual result was $7.4 million, up 3.68% from the prior year.
• Interest & Investment Income came in at -$96000.0 for Q3 2025 at ImageneBio, down from $1.3 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $7.0 million in Q4 2024 to a low of -$96000.0 in Q3 2025.
• The 5-year median for Interest & Investment Income is $782000.0 (2022), against an average of $1.2 million.
• Across the five-year window, Interest & Investment Income surged 20180.0% in 2022 and sank 308.7% in 2025, its largest moves.
• ImageneBio's Interest & Investment Income stood at $5000.0 in 2021, then soared by 20180.0% to $1.0 million in 2022, then surged by 123.96% to $2.3 million in 2023, then soared by 209.51% to $7.0 million in 2024, then plunged by 101.37% to -$96000.0 in 2025.
• The last three Interest & Investment Income figures came in at -$96000.0 (Q3 2025), $1.3 million (Q2 2025), and -$77000.0 (Q1 2025), per Business Quant data.